Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-002883-20Phase 4Active
Phase 4, open-label, single-arm trial of remifentanil and propofol, sponsored by University Medical Center Groningen. Started Jul 2013; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-002883-20.